A diazole is N-substituted with 1-trityl-2-methylaziridine and demethylated and oxidised with NBS under acidic conditions to give a benzimidazolequinone; this novel anti-tumour agent is marginally more cytotoxic than mitomycin C (MMC) towards the normal human fibroblast cell line GM00637, while the MMC-hypersensitive human Fanconi anaemia (FA) cell line, PD20i, lacking the FANCD2 protein, is also hypersensitive to the benzimidazolequinone, with expression of FANCD2 protein decreasing sensitivity to both MMC and the benzimidazolequinone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/b814706j | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.
Am J Hematol
February 2025
Joint Research Unit on Genomic Medicine, Universitat Autònoma de Barcelona (UAB)-IR SANT PAU, Barcelona, Spain.
Article Synopsis
- Fanconi anemia (FA) is a rare genetic disorder marked by varying symptoms and significant chromosome fragility, leading to severe health issues like cancer and bone marrow failure.
- The Spanish Registry of Patients with FA gathered data from 227 patients over 30 years, revealing an 86% cumulative cancer incidence by age 50, with outcomes differing based on chromosome fragility and specific gene mutations.
- Findings suggest that patients with mutations allowing some protein function (genetic hypomorphism) tend to have better health outcomes, indicating potential for new therapies that could enhance mutant FA protein function to improve patient prognosis.
PP2A licenses the FANCD2/FANCI complex for chromosome loading.
Cell Rep
November 2024
Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK. Electronic address:
The Fanconi anemia (FA) pathway removes interstrand crosslinks (ICLs) between the Watson-Crick strands of the DNA double helix in humans. Central to the pathway is the FANCD2/FANCI complex, which must be loaded onto chromosomes. Here, we report the identification of a PP2A phosphatase complex, which specifically dephosphorylates an inhibitory cluster in FANCD2, thereby licensing its loading in response to DNA damage.
View Article and Find Full Text PDFChemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2-/-, Fancg-/- (C57BL/6), Fancd2-/- (129/Sv) Mice.
In Vivo
October 2024
Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Article Synopsis
- - Radiation oncologists hesitate to treat cancer in Fanconi Anemia (FA) patients due to their inability to repair DNA strand breaks, leading to concerns about normal tissue damage during therapy.
- - Researchers created transplantable tumors in different strains of FA mice to study the impacts of radiation and chemotherapy on cancer development and progression.
- - The established FA tumor cell lines can serve as crucial models for testing innovative radiation therapy methods and treatment combinations tailored for radiosensitive FA patients.
The kinase ATR controls meiotic crossover distribution at the genome scale in Arabidopsis.
Plant Cell
December 2024
Laboratory of Genome Biology, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland.
Meiotic crossover, i.e. the reciprocal exchange of chromosome fragments during meiosis, is a key driver of genetic diversity.
View Article and Find Full Text PDFFANCD2 as a ferroptosis-related target for recurrent implantation failure by integrated bioinformatics and Mendelian randomization analysis.
J Cell Mol Med
October 2024
Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Article Synopsis
- Recurrent implantation failure (RIF) is a significant issue in assisted reproductive technology and may be influenced by endometrial factors like ferroptosis and immunity.
- The study utilized bioinformatics and Mendelian randomization to analyze differentially expressed ferroptosis-related genes (DEFRGs), identifying 11 key DEFRGs linked to RIF.
- Machine learning models highlighted MUC1, GJA1, and FANCD2 as potential biomarkers for RIF, with further validation in patients reinforcing the study's findings and suggesting FANCD2's protective role against RIF.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!